Haemonetics (NYSE:HAE) Releases FY 2024 Earnings Guidance :

Haemonetics (NYSE:HAE – Get Free Report) updated its FY 2024 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 3.750-3.950 for the period, compared to the consensus estimate of 3.890. The company issued revenue guidance of $1.3 billion-$1.3 billion, compared to the consensus revenue estimate of $1.3 billion. Haemonetics also updated […]

Related Keywords

United States , Ohio , , Barrington Research , Boothbay Fund Management , Haemonetics Corporation , Walleye Capital , Fintrust Capital Advisors , Haemonetics Company Profile , Citigroup , Get Free Report , Moderate Buy , Employees Retirement System , Fund Management , Trust Capital Advisors , Haemonetics Daily , Haemonetics , Nyse Hae , Hae , Medical , 40502410 , Guidance , Earnings , Preannouncement ,